KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism

Hypertension

Volumn 59, Issue 2, 2012, Pages 235-240

  Mulatero, Paolo ^a   Tauber, Philipp ^b   Zennaro, Maria Christina ^c,d,e   Monticone, Silvia ^a   Lang, Katharina ^f   Beuschlein, Felix ^g   Fischer, Evelyn ^g   Tizzani, Davide ^a   Pallauf, Anna ^g   Viola, Andrea ^a   Amar, Laurence ^c,d,e   Williams, Tracy Ann ^a   Strom, Tim M ^h   Graf, Elisabeth ^h   Bandulik, Sascha ^b   Penton, David ^b   Plouin, Pierre François ^c,d,e   Warth, Richard ^b   Allolio, Bruno ^f   Jeunemaitre, Xavier ^c,d,e   Veglio, Franco ^a   Reincke, Martin ^g   more..

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c INSERM   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^g LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^h INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Aldosterone; Endocrine hypertension; Familial hyperaldosteronism; KCNJ5; Primary aldosteronism

Indexed keywords

ALDOSTERONE; KCNJ5 POTASSIUM CHANNEL; POTASSIUM CHANNEL; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ADRENAL CORTEX ADENOMA; ADULT; ALDOSTERONE PRODUCING ADENOMA; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CYTOSOL; DISEASE ASSOCIATION; FAMILIAL DISEASE; FAMILIAL HYPERALDOSTERONISM; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PARAMETERS; HUMAN; HYPERTENSION; IN VITRO STUDY; ITALY; MALE; MEMBRANE DEPOLARIZATION; PHENOTYPE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL;

ADULT; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; G PROTEIN-COUPLED INWARDLY-RECTIFYING POTASSIUM CHANNELS; GLUCOCORTICOIDS; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PHENOTYPE; TREATMENT FAILURE;

EID: 84856300896     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.183996     Document Type: Article

References (26)

1. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM, for the Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline, J Clin Endocrinol Metab. 2008;93:3266-3281.
2. Mulatero P, Monticone S, Veglio F. Diagnosis and treatment of primary aldosteronism. Rev Endocr Metab Disord. 2011;12:3-9.
3. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45:1243-1248. (Pubitemid 40523144)
4. Born-Frontsberg E, Reincke M, Rump LC, Hahner S, Diederich S, Lorenz R, Allolio B, Seufert J, Schirpenbach C, Beuschlein F, Bidlingmaier M, Endres S, Quinkler M, Participants of the German Conn's Registry. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry. J Clin Endocrinol Metab. 2009;94:1125-1130.
5. Lifton RP, Dluhy RG, Powers M, Rich GM, Gutkin M, Fallo F, Gill JR Jr, Feld L, Ganguly A, Laidlaw JC. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet. 1992;2:66-74.
6. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Finn WL, Krek AL. Clinical and pathological diversity of primary aldosteronism, including a new familial variety. Clin Exp Pharmacol Physiol. 1991;18:283-286.
7. Geller DS, Zhang J, Wisgerhof MV, Shackleton C, Kashgarian M, Lifton RP. A novel form of human mendelian hypertension featuring nonglucocorticoid- remediable aldosteronism. J Clin Endocrinol Metab. 2008;93:3117-3123.
8. Mulatero P, Williams TA, Monticone S, Veglio F. Is familial hyperaldosteronism underdiagnosed in hypertensive children? Hypertension. 2011;57:1053-1055.
9. Mulatero P, Bertello C, Verhovez A, Rossato D, Giraudo G, Mengozzi G, Limerutti G, Avenatti E, Tizzani D, Veglio F. Differential diagnosis of primary aldosteronism subtypes. Curr Hypertens Rep. 2009;11:217-223.
10. Sukor N, Mulatero P, Gordon RD, So A, Duffy D, Bertello C, Kelemen L, Jeske Y, Veglio F, Stowasser M. Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families. J Hypertens. 2008;26:1577-1582.
11. So A, Duffy DL, Gordon RD, Jeske YW, Lin-Su K, New MI, Stowasser M. Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity. J Hypertens. 2005;23:1477-1484. (Pubitemid 41104818)
12. Choi M, Scholl UI, Yue P, Bjorklund P, Zhao B, Nelson-Williams C, Ji W, Cho Y, Patel A, Men CJ, Lolis E, Wisgerhof MV, Geller DS, Mane S, Hellman P, Westin G, Åkerstrom G, Wang W, Carling T, Lifton RP. K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science. 2011;331:768-772.
13. Mulatero P, Bertello C, Rossato D, Mengozzi G, Milan A, Garrone C, Giraudo G, Passarino G, Garabello D, Verhovez A, Rabbia F, Veglio F. Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab. 2008;93:1366-1371. (Pubitemid 351519734)
14. Mulatero P, Bertello C, Sukor N, Gordon R, Rossato D, Daunt N, Leggett D, Mengozzi G, Veglio F, Stowasser M. Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertension. 2010;55:667-673.
15. Mulatero P, Curnow KM, Aupetit-Faisant B, Foekling M, Gomez-Sanchez C, Veglio F, Jeunemaitre X, Corvol P, Pascoe L. Recombinant CYP11B genes encode enzymes that can catalyze conversion of 11-deoxycortisol to cortisol, 18-hydroxycortisol, and 18-oxocortisol. J Clin Endocrinol Metab. 1998;83:3996-4001. (Pubitemid 28513586)
16. Mulatero P, Tizzani D, Viola A, Bertello C, Monticone S, Mengozzi G, Schiavone D, Williams TA, Einaudi S, La Grotta A, Rabbia F, Veglio F. Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN Study (Primary Aldosteronism in TOrino-GENetic Forms). Hypertension. 2011;58:797-803.
17. Mulatero P, Veglio F, Pilon C, Rabbia F, Zocchi C, Limone P, Boscaro M, Sonino N, Fallo F. Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene. J Clin Endocrinol Metab. 1998;83:2573-2575. (Pubitemid 28503065)
18. Letavernier E, Peyrard S, Amar L, Zinzindohoué F, Fiquet B, Plouin PF. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma. J Hypertens. 2008;26:1816-1823.
19. Amar L, Plouin PF, Steichen O. Aldosterone-producing adenoma and other surgically correctable forms of primary aldosteronism. Orphanet J Rare Dis. 2010;19:5-9.
20. Betz MJ, Degenhart C, Fischer E, Pallauf A, Brand V, Linsenmaier U, Beuschlein F, Bidlingmaier M, Reincke M. Adrenal vein sampling using rapid cortisol assays in primary aldosteronism is useful in centers with low success rates. Eur J Endocrinol. 2011;165:301-306.
21. Fink M, Lesage F, Duprat F, Heurteaux C, Reyes R, Fosset M, Lazdunski M. A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids. EMBO J. 1998;17:3297-3308. (Pubitemid 28279504)
22. Mulatero P. A new form of hereditary primary aldosteronism: familial hyperaldosteronism type III. J Clin Endocrinol Metab. 2008;93:2972-2974.
23. Yang Y, Yang Y, Liang B, Liu J, Li J, Grunnet M, Olesen SP, Rasmussen HB, Ellinor PT, Gao L, Lin X, Li L, Wang L, Xiao J, Liu Y, Liu Y, Zhang S, Liang D, Peng L, Jespersen T, Chen YH. Identification of a Kir3.4 mutation in congenital long QT syndrome. Am J Hum Genet. 2010;86:872-880.
24. Morales A, Lachuer J, Bilbaut A, Georges B, Andrieu JL, Diez J, Ojeda C. Characterization of a Na +-Ca2+ exchanger NCX1 isoform in bovine fasciculata cells of adrenal gland. Mol Cell Biochem. 2001;218:41-45. (Pubitemid 32297582)
25. Mulatero P, Di Cella SM, Williams TA, Milan A, Mengozzi G, Bonelli S, Chiandussi L, Gomez-Sanchez CE, Veglio F. Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree. J Clin Endocrinol Metab. 2002;87:3187-3191. (Pubitemid 34816363)
26. Fallo F, Pilon C, Williams TA, Sonino N, Morra Di Cella S, Veglio F, De Iasio R, Montanari P, Mulatero P. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism. J Hum Hypertens. 2004;18:47-51. (Pubitemid 38165521)